AULIVIN

Serial Number 79346361
Registration 7147546
700

Registration Progress

Application Filed
Mar 22, 2022
Under Examination
Approved for Publication
Jun 13, 2023
Published for Opposition
Jun 13, 2023
Registered
Aug 29, 2023

Trademark Image

AULIVIN

Basic Information

Serial Number
79346361
Registration Number
7147546
Filing Date
March 22, 2022
Registration Date
August 29, 2023
Published for Opposition
June 13, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 29, 2023
Registration
Registered
Classes
005

Rights Holder

SinoCellTech Ltd.

03
Address
Rm. 301, No. 5 Building,
No. 31, Kechuang 7th Street, Beijing Eco
CN

Ownership History

SinoCellTech Ltd.

Original Applicant
03
CN

SinoCellTech Ltd.

Owner at Publication
03
CN

SinoCellTech Ltd.

Original Registrant
03
CN

Legal Representation

Attorney
Michael W. Piper

USPTO Deadlines

Next Deadline
1486 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-08-29)
Due Date
August 29, 2029
Grace Period Ends
February 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Dec 26, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 4, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Dec 4, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 29, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 29, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 29, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 13, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 13, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 12, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
May 24, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 24, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
May 24, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 9, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 2, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 2, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 2, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 2, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 2, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 17, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Feb 9, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 9, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 9, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 3, 2022 RFNP P REFUSAL PROCESSED BY IB Loading...
Sep 10, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 9, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Aug 19, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 18, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 16, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 2, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 29, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 28, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Vaccines; medicines for human purpose, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; biological preparations, namely, pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005